Zeitschriftenartikel zum Thema „Cer-001“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-45 Zeitschriftenartikel für die Forschung zum Thema "Cer-001" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Zheng, Kang He, Fleur M. van der Valk, Loek P. Smits, Mara Sandberg, Jean-Louis Dasseux, Rudi Baron, Ronald Barbaras et al. „HDL mimetic CER-001 targets atherosclerotic plaques in patients“. Atherosclerosis 251 (August 2016): 381–88. http://dx.doi.org/10.1016/j.atherosclerosis.2016.05.038.
Der volle Inhalt der QuelleOssoli, A., A. Strazzella, S. Simonelli, D. Rottoli, M. Abbate, C. M. Zoja, J. L. Dasseux und L. Calabresi. „Remodeling And Catabolism Of Cer-001 In Absence Of Lcat Enzyme“. Atherosclerosis 287 (August 2019): e107. http://dx.doi.org/10.1016/j.atherosclerosis.2019.06.312.
Der volle Inhalt der QuelleKeyserling, Constance H., Ronald Barbaras, Renee Benghozi und Jean-Louis Dasseux. „Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings“. Clinical Drug Investigation 37, Nr. 5 (17.02.2017): 483–91. http://dx.doi.org/10.1007/s40261-017-0506-3.
Der volle Inhalt der QuelleNicholls, Stephen J., Jordan Andrews, John J. P. Kastelein, Bela Merkely, Steven E. Nissen, Kausik K. Ray, Gregory G. Schwartz et al. „Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial“. JAMA Cardiology 3, Nr. 9 (01.09.2018): 815. http://dx.doi.org/10.1001/jamacardio.2018.2121.
Der volle Inhalt der QuelleLi, Chen, Pan Pan Wu und Kun Zhang. „Preparaitve Separation and Purification of Cordycepin from Cultured Cordyceps militaris Using Cation Exchange Resin“. Advanced Materials Research 550-553 (Juli 2012): 1773–78. http://dx.doi.org/10.4028/www.scientific.net/amr.550-553.1773.
Der volle Inhalt der QuelleFlores-Peña, Yolanda, María Eugenia Pérez-Campa, Hermelinda Ávila-Alpirez, Juana Mercedes Gutiérrez-Valverde und Gustavo Gutiérrez-Sánchez. „Depressive symptoms, maternal feeding styles, and preschool child’s body weight“. Salud mental 44, Nr. 6 (02.12.2021): 261–66. http://dx.doi.org/10.17711/sm.0185-3325.2021.034.
Der volle Inhalt der QuelleFaguer, Stanislas, Magali Colombat, Dominique Chauveau, Pauline Bernadet-Monrozies, Audrey Beq, Audrey Delas, Vincent Soler et al. „Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin–Cholesterol Acyltransferase Deficiency“. Annals of Internal Medicine 174, Nr. 7 (Juli 2021): 1022–25. http://dx.doi.org/10.7326/l20-1300.
Der volle Inhalt der QuelleNicholls, Stephen J., Jordan Andrews, John Jp Kastelein, Bela Merkely, Steven E. Nissen, Kausik Ray, Gregory G. Schwartz et al. „CARAT: will infusing a pre-beta high-density lipoprotein mimetic (CER-001) regress coronary atherosclerosis?“ Atherosclerosis 263 (August 2017): e10. http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.060.
Der volle Inhalt der QuelleOssoli, A., A. Strazzella, D. Rottoli, C. Zanchi, M. Locatelli, C. Zoja, S. Simonelli et al. „CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency“. Atherosclerosis 331 (August 2021): e39. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.112.
Der volle Inhalt der QuelleFaguer, S., M. Colombat, D. Chauveau, P. Bernadet, A. Delas, V. Soler, I. Labadens, A. Huart und J. Schanstra. „Place du mimétique HDL CER-001 dans la glomérulopathie secondaire aux déficits en lécithine-cholestérol acyltransférase (LCAT)“. Néphrologie & Thérapeutique 17, Nr. 5 (September 2021): 317–18. http://dx.doi.org/10.1016/j.nephro.2021.07.182.
Der volle Inhalt der QuellePavanello, Chiara, Marta Turri, Arianna Strazzella, Patrizia Tulissi, Stefano Pizzolitto, Giovanna De Maglio, Riccardo Nappi, Laura Calabresi und Giuliano Boscutti. „The HDL mimetic CER‐001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency“. Journal of Internal Medicine 291, Nr. 3 (11.11.2021): 364–70. http://dx.doi.org/10.1111/joim.13404.
Der volle Inhalt der QuelleZheng, Kang H., Yannick Kaiser, Casper C. van Olden, Raul D. Santos, Jean-Louis Dasseux, Jacques Genest, Daniel Gaudet et al. „No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels“. Atherosclerosis 311 (Oktober 2020): 13–19. http://dx.doi.org/10.1016/j.atherosclerosis.2020.08.004.
Der volle Inhalt der QuelleTardy, Claudine, Marine Goffinet, Nadia Boubekeur, Guy Cholez, Rose Ackermann, Gavin Sy, Constance Keyserling et al. „HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation“. PLOS ONE 10, Nr. 9 (03.09.2015): e0137584. http://dx.doi.org/10.1371/journal.pone.0137584.
Der volle Inhalt der QuelleLawrence, Caroline, Erica E. Fortune, Heather Badt, Kara Doughtie, Madyson L. Popalis und Melissa F. Miller. „Abstract P4-05-01: Cancer-Related Distress and Unmet Needs Among Triple Negative Breast Cancer Patients: Findings from the Cancer Experience Registry“. Cancer Research 83, Nr. 5_Supplement (01.03.2023): P4–05–01—P4–05–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-05-01.
Der volle Inhalt der QuelleAndrews, Jordan, Alex Janssan, Tracy Nguyen, Anthony D. Pisaniello, Daniel J. Scherer, John J. P. Kastelein, Bela Merkely et al. „Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study“. Cardiovascular Diagnosis and Therapy 7, Nr. 1 (Februar 2017): 45–51. http://dx.doi.org/10.21037/cdt.2017.01.01.
Der volle Inhalt der QuelleKataoka, Yu, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Jessica Fendler, Rishi Puri et al. „Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burden“. Cardiovascular Diagnosis and Therapy 7, Nr. 3 (Juni 2017): 252–63. http://dx.doi.org/10.21037/cdt.2017.02.01.
Der volle Inhalt der QuelleHovingh, G. K., E. S. Stroes, D. Gaudet, C. Stefanutti, H. Soran, S. Kwok, J. de Graaf et al. „Effects of CER-001 on carotid atherosclerosis by 3tmri in homozygous familial hypercholesterolemia (HoFH): The modifying orphan disease evaluation (mode) study“. Atherosclerosis 235, Nr. 2 (August 2014): e13-e14. http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.008.
Der volle Inhalt der QuelleTardif, J. C., C. M. Ballantyne, P. Barter, J. L. Dasseux, Z. A. Fayad, M. C. Guertin, J. J. P. Kastelein et al. „Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial“. European Heart Journal 35, Nr. 46 (29.04.2014): 3277–86. http://dx.doi.org/10.1093/eurheartj/ehu171.
Der volle Inhalt der QuelleTardy, Claudine, Marine Goffinet, Nadia Boubekeur, Rose Ackermann, Gavin Sy, Alice Bluteau, Guy Cholez et al. „CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice“. Atherosclerosis 232, Nr. 1 (Januar 2014): 110–18. http://dx.doi.org/10.1016/j.atherosclerosis.2013.10.018.
Der volle Inhalt der QuelleFranzin, Rossana, Alessandra Stasi, Marco Fiorentino, Irene Scalera, Monica Campioni, Maria Teresa Cimmarusti, Giuseppe Castellano et al. „CER-001, a Recombinant HDL, Modulates Ischemia/Reperfusion Injury (IRI) in Hypothermic (HMP) and Normothermic Perfusion (NMP) Solutions Through pAKT/eNOS Activation“. Journal of the American Society of Nephrology 34, Nr. 11S (November 2023): 23. http://dx.doi.org/10.1681/asn.20233411s123c.
Der volle Inhalt der QuelleKootte, Ruud S., Loek P. Smits, Fleur M. van der Valk, Jean-Louis Dasseux, Constance H. Keyserling, Ronald Barbaras, John F. Paolini et al. „Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA“. Journal of Lipid Research 56, Nr. 3 (05.01.2015): 703–12. http://dx.doi.org/10.1194/jlr.m055665.
Der volle Inhalt der QuelleKootte, R. S., L. P. Smits, F. M. van der Valk, J. L. Dasseux, C. Keyserling, R. Barbaras, J. Paolini et al. „Recombinant human apolipoprotein-a-i prebeta-HDL (cer-001) promotes reverse cholesterol transport and reduces carotid wall thickness in patients with genetically-determined low HDL“. Atherosclerosis 235, Nr. 2 (August 2014): e14. http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.009.
Der volle Inhalt der QuelleHovingh, G. Kees, Loek P. Smits, Claudia Stefanutti, Handrean Soran, See Kwok, Jacqueline de Graaf, Daniel Gaudet et al. „The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia“. American Heart Journal 169, Nr. 5 (Mai 2015): 736–42. http://dx.doi.org/10.1016/j.ahj.2015.01.008.
Der volle Inhalt der QuelleStroes, E., R. Benghozi, J. L. Dasseux, J. Genest, H. Ginsberg, C. Keyserling, E. Leitersdorf, P. Raggi und A. von Eckardstein. „A phase III multicentre, double-blind, placebo-controlled study (TANGO) to evaluate CER-001 on carotid atherosclerosis (vessel wall area) in patients with familial primary hypoalphalipoproteinaemia“. Atherosclerosis 252 (September 2016): e111-e112. http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.609.
Der volle Inhalt der QuelleLe, Loan, Daniel J. Schwartz, Risa Nakase-Richardson, Emily J. Almeida, William Anderson, Kevin Patel, Benjamin Sudolcan und Sagarika Nallu. „0556 Simultaneous comparison of unedited and manually edited HSAT with level 1 PSG in persons with hospitalized TBI“. SLEEP 46, Supplement_1 (01.05.2023): A245. http://dx.doi.org/10.1093/sleep/zsad077.0556.
Der volle Inhalt der QuelleKnapik, Katarzyna, Karolina Sieroń, Ewa Wojtyna, Grzegorz Onik, Ewa Romuk, Ewa Birkner, Agata Stanek, Aleksandra Kawczyk-Krupka, Ryszard Plinta und Aleksander Sieroń. „Precompetitional Weight Reduction Modifies Prooxidative-Antioxidative Status in Judokas“. Oxidative Medicine and Cellular Longevity 2019 (22.07.2019): 1–9. http://dx.doi.org/10.1155/2019/2164698.
Der volle Inhalt der QuelleCordeiro Juliani, Fabiana, Viviane Zorzanelli Rocha, Ana Paula Marte Chacra und Raul Dias dos Santos. „HIPOALFALIPOPROTEINEMIAS: DIAGNÓSTICO DIFERENCIAL, APRESENTAÇÃO CLÍNICA E DESAFIO TERAPÊUTICO“. Revista da Sociedade de Cardiologia do Estado de São Paulo 31, Nr. 1 (01.04.2021): 23–31. http://dx.doi.org/10.29381/0103-8559/2021310123-31.
Der volle Inhalt der QuelleDoughtie, Kara, Erica E. Fortune, Heather Badt, Caroline Lawrence, Madyson L. Popalis und Melissa F. Miller. „Abstract P6-05-29: Experience of Financial Toxicity and Distress Among Individuals Diagnosed with Triple Negative Breast Cancer: Findings from the Cancer Experience Registry“. Cancer Research 83, Nr. 5_Supplement (01.03.2023): P6–05–29—P6–05–29. http://dx.doi.org/10.1158/1538-7445.sabcs22-p6-05-29.
Der volle Inhalt der QuelleKuandykova, Elvira, Bakhitzhan Kuandykov, Sabit Daubassov, Manshuk Beysenbaeva, Duman Kussainov und Bayan Ashyralieva. „Legal basis of international agricultural organizations“. RIVISTA DI STUDI SULLA SOSTENIBILITA' 13, Nr. 1 (November 2023): 217–31. http://dx.doi.org/10.3280/riss2023-001-s1014.
Der volle Inhalt der QuelleStrobel, Sabine, und Thomas Schleid. „Quaternäre Strontium-Kupfer(I)-Lanthanoid(III)-Selenide mit Cer und Praseodym: SrCuCeSe3 und SrCuPrSe3, ein ungleiches Geschwisterpaar / Quaternary Strontium Copper(I) Lanthanoid(III) Selenides with Cerium and Praseodymium: SrCuCeSe3 and SrCuPrSe3, Unequal Brother and Sister“. Zeitschrift für Naturforschung B 59, Nr. 9 (01.09.2004): 985–91. http://dx.doi.org/10.1515/znb-2004-0907.
Der volle Inhalt der QuelleGoffinet, Marine, Claudine Tardy, Alice Bluteau, Nadia Boubekeur, Rudi Baron, Constance Keyserling, Ronald Barbaras, Narendra Lalwani und Jean-Louis Dasseux. „Abstract 18667: Anti-atherosclerotic Effect of CER-001, an Engineered HDL-mimetic, in the High-fat Diet-fed LDLr Knockout Mice“. Circulation 126, suppl_21 (20.11.2012). http://dx.doi.org/10.1161/circ.126.suppl_21.a18667.
Der volle Inhalt der QuelleStasi, Alessandra, Marco Fiorentino, Rossana Franzin, Francesco Staffieri, Sabrina Carparelli, Rosa Losapio, Alberto Crovace et al. „Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project“. BMC Medicine 21, Nr. 1 (02.11.2023). http://dx.doi.org/10.1186/s12916-023-03057-5.
Der volle Inhalt der QuelleBarbaras, Ronald. „Non-clinical development of CER-001“. Frontiers in Pharmacology 6 (06.10.2015). http://dx.doi.org/10.3389/fphar.2015.00220.
Der volle Inhalt der QuelleStasi, Alessandra, Rossana Franzin, Marco Fiorentino, Francesco Staffieri, Rosa Losapio, Maria Teresa Cimmarusti, Alberto Crovace et al. „#4015 RECOMBINANT HIGH-DENSITY LIPOPROTEIN MODULATES INFLAMMATORY RESPONSE AND RENAL DYSFUNCTION IN A SWINE MODEL OF SEPSIS-INDUCED ACUTE KIDNEY INJURY“. Nephrology Dialysis Transplantation 38, Supplement_1 (Juni 2023). http://dx.doi.org/10.1093/ndt/gfad063a_4015.
Der volle Inhalt der QuelleKalayci, Arzu, C. Michael Gibson, Paul M. Ridker, Samuel D. Wright, Bronwyn A. Kingwell, Serge Korjian, Gerald Chi et al. „ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future“. Current Atherosclerosis Reports, 07.05.2022. http://dx.doi.org/10.1007/s11883-022-01025-7.
Der volle Inhalt der QuelleFranzin, Rossana, Alessandra Stasi, Marco Fiorentino, Fabio Sallustio, Ronald Barbaras, Connie Peyrottes, Cyrille Tupin, Giuseppe Castellano, Paola Pontrelli und Loreto Gesualdo. „MO287: A Recombinant BIO-HDL (CER-001) Can Prevent SARS-COV2-Induced Renal Dysfunction by Restoring SR-BI Signalling“. Nephrology Dialysis Transplantation 37, Supplement_3 (Mai 2022). http://dx.doi.org/10.1093/ndt/gfac067.086.
Der volle Inhalt der QuelleKataoka, Yu, Jordan Andrews, MyNgan Duong, Tracy Nguyen, Nisha Schwarz, Jessica Fendler, Rishi Puri et al. „Abstract 12156: Greater Regression of Coronary Atherosclerosis With the Pre-Beta High-Density Lipoprotein Mimetic CER-001 in Patients With More Extensive Plaque Burden“. Circulation 132, suppl_3 (10.11.2015). http://dx.doi.org/10.1161/circ.132.suppl_3.12156.
Der volle Inhalt der QuelleFaguer, Stanislas, Arnaud Del Bello, Chloé Danet, Yves Renaudineau, Jacques Izopet und Nassim Kamar. „Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study“. Frontiers in Pharmacology 13 (26.09.2022). http://dx.doi.org/10.3389/fphar.2022.936659.
Der volle Inhalt der QuelleWoodall, J. M. „Contactless Electromodulation Characterization of Compound Semiconductor Surfaces and Device Structures“. MRS Proceedings 324 (1993). http://dx.doi.org/10.1557/proc-324-141.
Der volle Inhalt der QuelleOssoli, Alice, Arianna Strazzella, Daniela Rottoli, Cristina Zanchi, Monica Locatelli, Carlamaria Zoja, Sara Simonelli et al. „CER-001 ameliorates lipid profile and kidney disease in a mouse model of Familial LCAT Deficiency“. Metabolism, Dezember 2020, 154464. http://dx.doi.org/10.1016/j.metabol.2020.154464.
Der volle Inhalt der QuelleRomero, Natividad Calvo, Jesús Domínguez Delgado-Palacios, Marta Calvo Arevalo, Isabel Pérez-Flores, Beatriz Rodríguez Cubillo, María Ángeles Moreno de la Higuera Díaz, María Muñiz Rincón, Arianne Aiffil Meneses, Rómulo Katsu Loayza López und Ana Sanchez Fructuoso. „#5146 KINETIC ESTIMATION OF GFR AND URINARY CREATININE EXCRETION RATE AS PREDICTORS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTS FROM DECEASED DONORS“. Nephrology Dialysis Transplantation 38, Supplement_1 (Juni 2023). http://dx.doi.org/10.1093/ndt/gfad063c_5146.
Der volle Inhalt der QuelleQing, Shuiwang, Lei Gu, Tingting Du, Xiaolan Yin, Ke-jia Zhang und Huo-jun Zhang. „A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma“. Technology in Cancer Research & Treatment 22 (Januar 2023). http://dx.doi.org/10.1177/15330338231202893.
Der volle Inhalt der QuelleGoto, Ken, Tomo Ueno und Yoshinao Kumagai. „Heterostructure formation of group-III sesquioxides via cation-exchange reactions with metal chloride gases“. AIP Advances 13, Nr. 8 (01.08.2023). http://dx.doi.org/10.1063/5.0143736.
Der volle Inhalt der QuelleSrivastava, Rai Ajit K., Angelo B. Cefalu, Davide Noto, Donata Panno, Antonella Giammanco Giammanco und Maurizio R. Averna. „Abstract 9805: Lack of Correlation Between HDL Level and Fecal Cholesterol in Multiple Mouse Models Suggests Importance of HDL Functionality in Atherosclerosis Attenuation“. Circulation 132, suppl_3 (10.11.2015). http://dx.doi.org/10.1161/circ.132.suppl_3.9805.
Der volle Inhalt der QuelleDoebele, Robert C., Laura Perez, Huong Trinh, Michael Martinec, Reynaldo Martina, Todd Riehl, Matthew G. Krebs, Neal J. Meropol, William B. Wong und Gracy Crane. „Comparative effectiveness analysis between entrectinib clinical trial and crizotinib real-world data in ROS1+ NSCLC“. Journal of Comparative Effectiveness Research, 24.08.2021. http://dx.doi.org/10.2217/cer-2021-0131.
Der volle Inhalt der Quelle